Adenoviral-mediated systemic administration of candidate therapeutic genes in a model of genetic hypertension

Adenoviral-mediated systemic administration of candidate therapeutic genes in a model of genetic hypertension

Bibliographic Details
Main Authors:	Miller, W, Brosnan, M, Graham, D, Frater, A, Channon, K, Reynolds, P, Baker, A, Dominiczak, A
Format:	Conference item
Published:	2003

Similar Items

Endothelial targeting of adenoviral vectors expressing eNOS lowers blood pressure in a rat model of genetic hypertension
by: Miller, W, et al.
Published: (2004)

Systemic gene transfer of oxidant stress genes and blood pressure in a model of genetic hypertension
by: Miller, W, et al.
Published: (2003)

Sustained lowering of systolic blood pressure using an endothelial cell-targeted adenoviral vector
by: Miller, W, et al.
Published: (2004)

Targeted delivery of adenovirus expressing eNOS to the endothelium in vivo lowers blood pressure in hypertensive rats
by: Miller, W, et al.
Published: (2004)

Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats.
by: Miller, W, et al.
Published: (2005)

Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats.
by: Brosnan, M, et al.
Published: (2002)

Optimisation of adenoviral and plasmid-mediated gene transfer to the murine myocardium
by: Griesenbach, U, et al.
Published: (2004)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
by: Qiwei Zhang, et al.
Published: (2022-03-01)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
by: Tasneem Farhad, et al.
Published: (2022-10-01)

Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2003)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
by: Meirong Wang, et al.
Published: (2021-03-01)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Kelly, C, et al.
Published: (2011)

Adenoviral vectors for gene therapy /
by: Curiel, David T., et al.
Published: (2002)

Quantitative analysis of adenoviral vector modification of a cytokine-mediated cell death decision
by: Miller, Kathryn Elizabeth
Published: (2008)

Adenoviral Keratoconjunctivitis
by: Alexander Bialasiewicz
Published: (2007-04-01)

CELO Fiber1 Knob Is a Promising Candidate to Modify the Tropism of Adenoviral Vectors
by: Yangyang Sun, et al.
Published: (2022-12-01)

Adenoviral-mediated delivery of a CC-chemokine inhibitor ('35K') attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
by: Bursill, C, et al.
Published: (2004)

Systematic analysis of 123 candidate genes reveals two novel genes for hypertension
by: Brown, M, et al.
Published: (2008)

Candidates for Intra-Articular Administration Therapeutics and Therapies of Osteoarthritis
by: Eriko Toyoda, et al.
Published: (2021-03-01)

The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications
by: Cristian Capasso, et al.
Published: (2014-02-01)

Adenoviral mediated delivery of a CC chemokine (CK) inhibitor ("35K") attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
by: Bursill, C, et al.
Published: (2004)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
by: Goodman, A, et al.
Published: (2009)

Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene Therapy
by: Alnawaz Rehemtulla, et al.
Published: (2002-01-01)

Glycoviruses: chemical glycosylation retargets adenoviral gene transfer.
by: Pearce, O, et al.
Published: (2005)

Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
by: Qian, H, et al.
Published: (2001)

Adenoviral mediated delivery of a vaccinia viral protein (35K) blocks CC-chemokine activity in vitro and in vivo and may therefore be a useful therapeutic strategy to reduce the initiation and progression of CC-chemokine induced atherosclerosis
by: Bursill, C, et al.
Published: (2003)

Readministration of adenoviral gene delivery to dopamine neurons.
by: Gonzalez, S, et al.
Published: (2007)

Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy
by: Siemionow Maria, et al.
Published: (2006-08-01)

Immune responses to adenoviral vectors during gene transfer in the brain.
by: Kajiwara, K, et al.
Published: (1997)

Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries
by: Julian Fischer, et al.
Published: (2024-06-01)

Engineering Adenoviral Vectors with Improved GBM Selectivity
by: Emily A. Bates, et al.
Published: (2023-04-01)

Construction and application of adenoviral vectors
by: Hongbo Zhang, et al.
Published: (2023-12-01)

Pathogenesis and management of adenoviral keratoconjunctivitis
by: Chigbu DI, et al.
Published: (2018-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Ewer (nee Russell), K, et al.
Published: (2017)

AN ADENOVIRAL MODEL TO UNLOCK THE SECRETS OF MEMORY INFLATION?
by: Colston, J, et al.
Published: (2013)

Spinal Cord Molecular and Cellular Changes Induced by Adenoviral Vector- and Cell-Mediated Triple Gene Therapy after Severe Contusion
by: Andrei A. Izmailov, et al.
Published: (2017-11-01)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
by: von Delft, A, et al.
Published: (2017)

Candidate and non-candidate genes in behavior genetics.
by: Flint, J, et al.
Published: (2013)

Candidate and non-candidate genes in behavior genetics
by: Flint, J, et al.
Published: (2013)

The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade
by: Sajad Najafi, et al.
Published: (2023-05-01)